Association between lower urinary tract symptoms and polycystic ovary syndrome

SUMMARY OBJECTIVE: The aim of this study was to analyze the association between lower urinary tract symptoms and polycystic ovary syndrome. METHODS: A total of 180 women were enrolled in this prospective study. Demographic data, body mass index, waist circumference, modified Ferriman–Gallwey scores, biochemical parameters, ultrasonographic findings, and maximum urinary flow rate (Q max) were analyzed. In addition, the Beck Depression Inventory, Beck Anxiety Inventory, and Bristol Female Lower Urinary Tract Symptom Scored Form questionnaires were evaluated for each subject. RESULTS: The mean age of patients was calculated as 23.78±3.04 years, which was similar for both groups (p=0.340). Body mass index, waist circumference, Beck Depression Inventory, Beck Anxiety Inventory, Bristol Female Lower Urinary Tract Symptom Scored Form, and modified Ferriman–Gallwey scores were significantly higher in group 2 (p<<0.001). Hyperandrogenism, lipid profile, and glucose metabolism disorders were more frequent in group 2 (p<<0.05). Bladder capacity (Q max), bladder wall thickness, and post-void residual volume values were similar in both groups (p>>0.05). CONCLUSION: In our study, a close relationship was observed between polycystic ovary syndrome and lower urinary tract symptoms. In this context, we think that a detailed urinary system evaluation of women with polycystic ovary syndrome is extremely important.

[1]  A. L. M. Silveira,et al.  Metabolic and behavioral effects of time-restricted eating in women with overweight or obesity: Preliminary findings from a randomized study. , 2022, Nutrition.

[2]  Selim Gülücü,et al.  Total cholesterol/high-density lipoprotein and inflammatory parameters in patients with polycystic ovary syndrome , 2022, Revista da Associacao Medica Brasileira.

[3]  M. C. Baracat,et al.  Are there new insights for the definition of PCOS? , 2022, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[4]  Ç. Şenocak,et al.  THE EFFECT OF BLADDER PAIN SYNDROME/INTERSTITIAL CYSTITIS ON PARTNER SEXUAL FUNCTIONS , 2022, Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi.

[5]  S. Şahin,et al.  The prevalence of urinary incontinence in obese women and its effect on quality of life , 2021, Health care for women international.

[6]  M. Soliman,et al.  The Prevalence of Overactive Bladder Symptoms in Women in Algeria, Egypt, Jordan and Lebanon: A Cross-Sectional Population-Based Survey , 2020, Advances in Therapy.

[7]  C. Juliato,et al.  Pelvic floor parameters in women with gynecological endocrinopathies: a systematic review. , 2020, Revista da Associacao Medica Brasileira.

[8]  C. H. Chan,et al.  The mental health of women with polycystic ovary syndrome: a systematic review and meta-analysis , 2020, Archives of Women's Mental Health.

[9]  F. Ramezani Tehrani,et al.  Polycystic Ovary Syndrome and Pelvic Floor Dysfunction: A Narrative Review , 2020, Research and reports in urology.

[10]  E. Baracat,et al.  Kisspeptin Influence on Polycystic Ovary Syndrome—a Mini Review , 2020, Reproductive Sciences.

[11]  S. Perna,et al.  Polycystic ovary syndrome management: a review of the possible amazing role of berberine , 2020, Archives of Gynecology and Obstetrics.

[12]  F. Heidari,et al.  The Relationship between Chronic Lower Urinary Tract Symptoms and Psychological Disorders in Women Referring to Baqyiatallah Hospital Clinic in Tehran City , 2019 .

[13]  B. Gillespie,et al.  Relationship Between Central Obesity, General Obesity, Overactive Bladder Syndrome and Urinary Incontinence Among Male and Female Patients Seeking Care for Their Lower Urinary Tract Symptoms. , 2019, Urology.

[14]  M. Averbeck,et al.  The prevalence of lower urinary tract symptoms (LUTS) in Brazil: Results from the epidemiology of LUTS (Brazil LUTS) study , 2018, Neurourology and urodynamics.

[15]  S. Sahin,et al.  The impact of obesity on clinical, metabolic and hormonal features in patients with polycystic ovary syndrome , 2014 .

[16]  R. Ferriani,et al.  Pelvic floor muscle strength and urinary incontinence in hyperandrogenic women with polycystic ovary syndrome , 2013, International Urogynecology Journal.

[17]  C. Gokkaya,et al.  Validation of Turkish Version of Bristol Female Lower Urinary Tract Symptom Index , 2012 .

[18]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[19]  E. Ozturk,et al.  The relationship between serum testosterone levels and bladder storage symptoms in a female population with polycystic ovary syndrome , 2011, Archives of Gynecology and Obstetrics.

[20]  M. Tek,et al.  The effect of testosterone replacement therapy on bladder functions and histology in orchiectomized mature male rats. , 2010, Urology.

[21]  M. Tek,et al.  The effect of testosterone alone and testosterone + estradiol therapy on bladder functions and smooth muscle/collagen content in surgically menopause induced rats. , 2008, Maturitas.

[22]  C. Chien,et al.  Bladder dysfunction in rats with metabolic syndrome induced by long-term fructose feeding. , 2008, The Journal of urology.

[23]  Juei-Tang Cheng,et al.  Alterations of M2,3-muscarinic receptor protein and mRNA expression in the bladder of the fructose fed obese rat. , 2007, The Journal of urology.

[24]  M. Cedars,et al.  Clinical course of depression symptoms and predictors of enduring depression risk in women with polycystic ovary syndrome: Results of a longitudinal study. , 2019, Fertility and sterility.